Shortcuts

open access

Vol 7, No 2 (2005)
Prace poglądowe
Published online: 2005-09-12
Get Citation

Hemorrhagic stroke as a complication of fibrynolytic treatment in myocardial infarction

Bożena Zięba, Dariusz Gąsecki, Marcin Gruchała, Andrzej Rynkiewicz, Walenty M. Nyka, Jerzy Bellwon, Agnieszka Węgrzyn
Udar Mózgu. Problemy Interdyscyplinarne 2005;7(2):48-55.

open access

Vol 7, No 2 (2005)
Prace poglądowe
Published online: 2005-09-12

Abstract

Thromboembolic stroke most often occurs in patients who do not receive fibrynolytic treatment. Intracranial hemorrhage is the most common form of stroke in patients receiving thrombolytic therapy. Majority of thromboembolic stroke occures more than 48 hours after fibrynolytic therapy administration. Hemorrhagic stroke usually occurs in the first 24 hours after fibrynolytic therapy. It is well known that some groups of patients have high risk intracranial hemorrhage as a complication of thrombolytic treatment of myocardial infarction. Fibrynolytic therapy reduces risk of death in myocardial infarction with ST segment elevation and is commonly used in many hospitals. The risk of as serious complication as cerebral hemorrhage, which can cause impaired neurological functions or even death, is very high in patients with recent myocardial infarction and stoke in history, so in this situations primary percutaneous angioplasty should be prefered.

Abstract

Thromboembolic stroke most often occurs in patients who do not receive fibrynolytic treatment. Intracranial hemorrhage is the most common form of stroke in patients receiving thrombolytic therapy. Majority of thromboembolic stroke occures more than 48 hours after fibrynolytic therapy administration. Hemorrhagic stroke usually occurs in the first 24 hours after fibrynolytic therapy. It is well known that some groups of patients have high risk intracranial hemorrhage as a complication of thrombolytic treatment of myocardial infarction. Fibrynolytic therapy reduces risk of death in myocardial infarction with ST segment elevation and is commonly used in many hospitals. The risk of as serious complication as cerebral hemorrhage, which can cause impaired neurological functions or even death, is very high in patients with recent myocardial infarction and stoke in history, so in this situations primary percutaneous angioplasty should be prefered.
Get Citation

Keywords

intracerebral hemorrhage; fibrynolytic treatment; myocardial infarction complications

About this article
Title

Hemorrhagic stroke as a complication of fibrynolytic treatment in myocardial infarction

Journal

Interdisciplinary Problems of Stroke

Issue

Vol 7, No 2 (2005)

Pages

48-55

Published online

2005-09-12

Bibliographic record

Udar Mózgu. Problemy Interdyscyplinarne 2005;7(2):48-55.

Keywords

intracerebral hemorrhage
fibrynolytic treatment
myocardial infarction complications

Authors

Bożena Zięba
Dariusz Gąsecki
Marcin Gruchała
Andrzej Rynkiewicz
Walenty M. Nyka
Jerzy Bellwon
Agnieszka Węgrzyn

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl